Evidence map›Paper›PMID 21177335›Full record

ArticleCardiovascular research2011

The paradoxical world of protein O-GlcNAcylation: a novel effector of cardiovascular (dys)function.

Susan A Marsh, John C Chatham

Abstract readCommentEditorial
In one paragraph

Article in Cardiovascular research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Consuming sucrose solution promotes leptin resistance and site specifically modifies hypothalamic leptin signaling in rats.American journal of physiology. Regulatory, integrative and comparative physiology · 2021
    Article
  2. Review
  3. Source of dietary sucrose influences development of leptin resistance in male and female rats.American journal of physiology. Regulatory, integrative and comparative physiology · 2018
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Susan A Marsh
John C Chatham

Funding

TYPE 2 DIABETES AND CARDIAC DYSFUNCTIONR01HL067464 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHATHAM, JOHN C · 2000 to 2009
$1.9M
Mechanisms of glucosamine ischemic cardioprotectionR01HL079364 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHATHAM, JOHN C · 2006 to 2010
$1.9M
Protein O-GlcNAcylation and the regulation of cardiac functionR01HL101192 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHATHAM, JOHN C · 2010 to 2014
$1.5M
NHLBI NIH HHS HL079364NHLBI NIH HHS HL101192NHLBI NIH HHS HL67464NHLBI NIH HHS R01 HL101192
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcetylglucosamineAcylationAnimalsCardiovascular DiseasesEndothelin-1Humansrho-Associated KinasesAcetylglucosamineEndothelin-1rho-Associated Kinases

Identifiers

PMID21177335
PMCPMC3028980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.